Please login to the form below

Not currently logged in
Email:
Password:

Bowel cancer

This page shows the latest Bowel cancer news and features for those working in and with pharma, biotech and healthcare.

The Communiqué Awards at 20: Mark Flannagan

The Communiqué Awards at 20: Mark Flannagan

The Communiqué Awards at 20: Mark Flannagan. Beating Bowel Cancer's former chief executive on changes in healthcare comms. ... Chief executive, Beating Bowel Cancer. Left on 31 March 2017 to set up as an independent consultant and strategic counsel.

Latest news

  • The UK's new Cancer Drugs Fund The UK's new Cancer Drugs Fund

    The new CDF started operating at the end of July, with four new cancer drugs made available under the scheme. ... Gaining the greenlight were Novartis' Zykadia (ceritinib) for lung cancer and melanoma combination Tafinlar (dabrafenib) and Mekinist

  • Controversial new CDF promises Controversial new CDF promises "clearer, faster decision-making"

    The UK's new Cancer Drugs Fund (CDF) started operating last Friday, with four new cancer drugs made available under the scheme. ... bowel cancer.

  • Charity of the Year for Ellie's Friends at 2016 Communiqué Awards Charity of the Year for Ellie's Friends at 2016 Communiqué Awards

    And a high commendation for Beating Bowel Cancer. The inaugural Charity, Patient or Professional Association of the Year at Communiqué 2016 was awarded to Ellie's Friends by the Eleanor Rose ... Foundation. The Foundation saw off competition from The

  • Finalists revealed for Communiqué Awards 2016 Finalists revealed for Communiqué Awards 2016

    Joining them are charities that include Beating Bowel Cancer and the Genetic Alliance, and pharma companies such as AbbVie, AstraZeneca, Celgene, Medtronic, Novartis and Roche, to name but a few. ... Sophie Mansfield. 90TEN. AbbVie. Aurora. Beating Bowel

  • Cancer charities criticise NICE's 'last-century methodology' Cancer charities criticise NICE's 'last-century methodology'

    Medical charities in the UK have warned that revised plans for approving cancer drugs will result in fewer being available to patients. ... One of the signatories of the letter is Beating Bowel Cancer, which said in a statement: "Ultimately, this means

More from news
Approximately 7 fully matching, plus 68 partially matching documents found.

Latest Intelligence

  • Case study: Cancer cookbook Case study: Cancer cookbook

    with cancer, enhance the reputation of Eisai among key stakeholders, build mutual trust and be genuinely ‘ different’. ... Penny Ericson, a best-selling cookery author, chef and wife of bowel cancer patient Simon, was identified to collaborate with

  • Case study: Cancer cookbook Case study: Cancer cookbook

    with cancer, enhance the reputation of Eisai among key stakeholders, build mutual trust and be genuinely ‘ different’. ... Penny Ericson, a best-selling cookery author, chef and wife of bowel cancer patient Simon, was identified to collaborate with

  • Evidence-based patient pathways for mCRC Evidence-based patient pathways for mCRC

    Published: 13 Sep 2012. Client:Beating Bowel Cancer. Agency:Tonic Life Communications. Campaign:Treating Liver Metastases: Saving Lives. ... To address this variation in care, Beating Bowel Cancer, in partnership with Tonic Life Communications, developed

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Bowel Cancer Awareness Month

    Bowel cancer is one of most common cancers diagnosed in the UK, but with early diagnosis and treatment, most cases can be treated successfully. ... To raise awareness, we’ ve created this infographic with some facts on bowel cancer in the UK.

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics